[Effects of Aldatense on laboratory tests. Comparison with a reference population].
Aldatense effects on laboratory test results were studied in two subjects groups. - A treated group was paired with an untreated hypertensive group. In these conditions, some parameters were increased by 10 to 20 p. cent (creatinine, urea, phosphate, urate) or by 30 p. cent (triglycerides), others decreased by 40 p. cent (alkaline phosphatases) and 80 p. cent (gamma glutamyltransferase). The treated population was characterized either by values near to reference values (urea, creatinine, phosphate, calcium, albumin, gamma glutamyltransferase), by decreased values (alkaline phosphatases, triglycerides) or by increased values (urate).
D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001769:Blood / Q000187:drug effects*; D002191:Canrenoic Acid / Q000494:pharmacology*; D004338:Drug Combinations / Q000494:pharmacology; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011245:Pregnadienes / Q000494:pharmacology*; D012016:Reference Values; D012110:Reserpine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D013449:Sulfonamides / Q000494:pharmacology*
D000959:Antihypertensive Agents; D004338:Drug Combinations; D011245:Pregnadienes; D013449:Sulfonamides; C006445:althiazide, canrenoate potassium, rescinnamine drug combination; D002191:Canrenoic Acid; D012110:Reserpine
Effets de l'Aldatense sur les examens de laboratoire. Comparaison avec la population de référence.